Randomized run-in study of bevacizumab and everolimus in low-to intermediate- grade neuroendocrine tumors (LGNETs) using perfusion CT (pCT) as functional biomarker

Category Primary study
JournalPancreas
Year 2011
This article has no abstract
Epistemonikos ID: 0bed5ce322e88c23f4624961636acc33160c4296
First added on: Feb 04, 2025